
402MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1710774076
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
25.10
PEG Ratio
-
Book Value
0.96
Dividend Share
-
Dividend Yield
-
Earnings Share
0.2
Wall Street Target Price
13.60
EPS Estimate Current Year
0.24
EPS Estimate Next Year
0.32
EPS Estimate Current Quarter
0.0167
EPS Estimate Next Quarter
0.055
Most Recent Quarter
-
Revenue TTM
129,423,000
Gross Profit TTM
83,189,000
EBITDA
15,081,000
Profit Margin
13.43%
Return On Assets TTM
10.23%
Return On Equity TTM
28.35%
Revenue Per Share TTM
1.635
Qtly Revenue Growth YOY
16.20%
Diluted Eps TTM
0.2
Qtly Earnings Growth YOY
-41.60%
Trailing PE
25.10
Forward PE
19
Price Sales TTM
3.1061
Price Book MRQ
5.2527
Enterprise Value Revenue
2
Enterprise Value EBITDA
21
296.54
5.93%92.39
1.30%143.34
1.23%300.24
0.10%304.44
-3.05%745.90
-2.64%798.48
-1.56%430.33
-1.16%22.83
-0.91%781.13
-0.90%